![Bradley Sitko](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Bradley Sitko
Direttore degli Investimenti presso XOMA CORPORATION
Patrimonio netto: 233 269 $ in data 31/05/2024
Profilo
Bradley J.
Sitko is currently a Managing Director at RTW Investments and a Chief Investment Officer at XOMA Corp.
He was previously a Director at MTS Health Partners LP from 2008 to 2015, a Vice President-Finance & Corporate Development at DNAnexus, Inc. from 2015 to 2019, and a Director at RTW Investments ICAV from 2021 to 2023.
He also held a position as a Chief Financial Officer at Jixing Pharmaceutical Technology (Shanghai) Co. Ltd.
Additionally, he has worked as a Principal at Pfizer Inc. Mr. Sitko received his undergraduate degree from the University of Pennsylvania and his MBA from Columbia Business School.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
XOMA CORPORATION
0.06% | 18/03/2024 | 7 100 ( 0.06% ) | 183 109 $ | 31/05/2024 |
02/10/2023 | 2 000 ( 0.13% ) | 50 160 $ | 31/05/2024 |
Posizioni attive di Bradley Sitko
Società | Posizione | Inizio |
---|---|---|
XOMA CORPORATION | Direttore degli Investimenti | 03/01/2023 |
RTW Investments /Venture/
![]() RTW Investments /Venture/ Investment ManagersFinance RTW Investments /Venture/ (RTW Investments) is a venture capital subsidiary of RTW Investments LP founded in 2009 by Roderick Wong. The firm is headquartered in New York. | Investitore di Private Equity | 01/11/2019 |
Precedenti posizioni note di Bradley Sitko
Società | Posizione | Fine |
---|---|---|
RTW Investments ICAV | Direttore/Membro del Consiglio | 01/01/2023 |
DNAnexus, Inc.
![]() DNAnexus, Inc. Packaged SoftwareTechnology Services DNAnexus, Inc. develops a cloud-based data analysis and management platform for DNA sequence data. It engages in the provision of cloud-based solutions for large-scale Deoxyribonucleic acid (DNA) data management and analysis. The firm offers a centralized hub for managing data, collaborating with other scientists, sharing tools, and accessing diverse reference datasets, including genotypic and phenotypic data. The company was founded by Serafim Batzoglou, Andreas Sundquist and Arend Sidow in 2009 and is headquartered in Mountain View, CA. | Direttore Finanziario/CFO | 01/01/2019 |
MTS Health Partners LP
![]() MTS Health Partners LP Investment Banks/BrokersFinance MTS Health Partners LP provides strategic and financial advisory services to healthcare companies from global corporations to venture backed businesses. Its strategic advisory alternatives include mergers, acquisitions, company sales, divestitures, recapitalizations, restructurings, general strategic advisory, financing oversight and oversight opinions. The firms financing solutions include traditional private convertible preferred issuances, cross-over focused convertible transactions, common stock and structured/convertible PIPEs, registered direct and acquisition financings, secondary sales, special situations, structured debt financings and royalty monetization. The company was founded by Curtis Scott Lane in 2000 and is headquartered in New York, NY. | Direttore/Membro del Consiglio | 01/03/2015 |
Jixing Pharmaceutical Technology (Shanghai) Co. Ltd.
![]() Jixing Pharmaceutical Technology (Shanghai) Co. Ltd. Pharmaceuticals: MajorHealth Technology Jixing Pharmaceutical Technology (Shanghai) Co. Ltd. is a Chinese company that develops and commercializes novel therapeutics. Yan Ping Mou has been the CEO of the company since 2023. | Direttore Finanziario/CFO | - |
PFIZER, INC. | Corporate Officer/Principal | - |
Formazione di Bradley Sitko
University of Pennsylvania | Undergraduate Degree |
Columbia Business School | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
PFIZER, INC. | Health Technology |
XOMA CORPORATION | Health Technology |
Aziende private | 5 |
---|---|
DNAnexus, Inc.
![]() DNAnexus, Inc. Packaged SoftwareTechnology Services DNAnexus, Inc. develops a cloud-based data analysis and management platform for DNA sequence data. It engages in the provision of cloud-based solutions for large-scale Deoxyribonucleic acid (DNA) data management and analysis. The firm offers a centralized hub for managing data, collaborating with other scientists, sharing tools, and accessing diverse reference datasets, including genotypic and phenotypic data. The company was founded by Serafim Batzoglou, Andreas Sundquist and Arend Sidow in 2009 and is headquartered in Mountain View, CA. | Technology Services |
MTS Health Partners LP
![]() MTS Health Partners LP Investment Banks/BrokersFinance MTS Health Partners LP provides strategic and financial advisory services to healthcare companies from global corporations to venture backed businesses. Its strategic advisory alternatives include mergers, acquisitions, company sales, divestitures, recapitalizations, restructurings, general strategic advisory, financing oversight and oversight opinions. The firms financing solutions include traditional private convertible preferred issuances, cross-over focused convertible transactions, common stock and structured/convertible PIPEs, registered direct and acquisition financings, secondary sales, special situations, structured debt financings and royalty monetization. The company was founded by Curtis Scott Lane in 2000 and is headquartered in New York, NY. | Finance |
RTW Investments /Venture/
![]() RTW Investments /Venture/ Investment ManagersFinance RTW Investments /Venture/ (RTW Investments) is a venture capital subsidiary of RTW Investments LP founded in 2009 by Roderick Wong. The firm is headquartered in New York. | Finance |
RTW Investments ICAV | Miscellaneous |
Jixing Pharmaceutical Technology (Shanghai) Co. Ltd.
![]() Jixing Pharmaceutical Technology (Shanghai) Co. Ltd. Pharmaceuticals: MajorHealth Technology Jixing Pharmaceutical Technology (Shanghai) Co. Ltd. is a Chinese company that develops and commercializes novel therapeutics. Yan Ping Mou has been the CEO of the company since 2023. | Health Technology |
- Borsa valori
- Insiders
- Bradley Sitko